H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. — Tampa, Florida

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. is a clinical research site located in Tampa, Florida, United States 33612-9497.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors (Phase 1), RAS Mutation.

Sponsors: Adlai Nortye Biopharma Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for H. Lee Moffit Cancer Center and Research Institute Hospital, Inc.?

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. conducted?

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors (Phase 1), RAS Mutation.

Is H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. accredited by Crixeo Clinical Trials?

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about H. Lee Moffit Cancer Center and Research Institute Hospital, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.